US regulator, Amgen reach deal to unblock biopharma acquisition
The US Federal Trade Commission (FTC) announced an agreement on Friday allowing American drug manufacturer Amgen to proceed with its $28 billion takeover of Horizon Therapeutics.
Sep 1, 2023
0
4